Bank7

Bank7 Corp is assigned a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 6% discount to our quantitative fair value estimate of $58.36 per share; however, caution is warranted due to this estimate's high uncertainty rating.

The company's solid growth increases our valuation estimate. Consistent revenue and earnings growth indicates a company's potential for increased market share and profitability. For example, the firm's EPS 5-year growth of 13.2% falls in the top 40% compared with global peers. The robust five-year track record of EPS growth is reason to be optimistic about the firm's shares. We believe this is a sign that shares could be undervalued.

Conversely, the company's liquidity is potentially concerning. Low liquidity can inhibit a company from meeting short-term obligations, potentially reducing financial stability and increasing distress risk. The firm's median trading volume over the past 60 days, a core component of liquidity, ranks in the bottom 40% globally. Relatively low trading volume for these shares could lead to prices that don't accurately reflect the intrinsic value of shares. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is undervalued, this outperformance had a negative impact on our valuation estimate.

The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.